Medicines Formulary

Medicines A–Z

B

Drug name	NICE TAs	Comments
Bonjela oral gel
Boric Acid Vaginal Pessaries		For resistant vaginal candidiasis in line with BASHH guidelines.
Bortezomib injection	TA228 - Blinatumomab for previously treated Philadelphia-chromosome-negative acute lymphoblastic leukaemia TA129 - Bortezomib monotherapy for relapsed multiple myeloma TA311 - Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation	National CDF list. Hospital use only.
Bosentan
Bosentan tablets		Hospital only. NHS England commissioned.
Bosutinib	TA311 - Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation
Botox A	TA260 - Botulinum toxin type A for the prevention of headaches in adults with chronic migraine
Botulinum A toxin injection		Botox, Dysport and Xeomin. To be prescribed by brand
Botulinum toxin type A
Botulinum toxin type A (Botox)		For hyperhidrosis

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.